Dr. Reddy's Laboratories
RDY
#1800
Rank
NZ$19.20 B
Marketcap
NZ$22.87
Share price
1.47%
Change (1 day)
-5.84%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - P/B ratio

P/B ratio as of February 2026 : 2.84

According to Dr. Reddy's Laboratories's latest financial reports the company has a price-to-book ratio of 2.92659.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Dr. Reddy's Laboratories - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-312.84-20.81%
2024-12-313.59-0.93%
2023-12-313.6312.3%
2022-12-313.23-24.69%
2021-12-314.29-15.54%
2020-12-315.0858.75%
2019-12-313.20-0.02%
2018-12-313.20-0.93%
2017-12-313.23-22.95%
2016-12-314.191.86%
2015-12-314.11-21.78%
2014-12-315.263.95%
2013-12-315.068.79%
2012-12-314.65-9.51%
2011-12-315.14-12.02%
2010-12-315.8422.8%
2009-12-314.75215.25%
2008-12-311.51-43.4%
2007-12-312.66-24.06%
2006-12-313.516.03%
2005-12-313.31-0.36%
2004-12-313.32-37.28%
2003-12-315.3036.07%
2002-12-313.89

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
6.45 126.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.57-44.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.34-53.00%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
5.06 77.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
5.70 100.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel